Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 27, 2026

Apr. 27, 2026

CAAM Introduces a Modern Approach to Facial Cold Therapy Rooted in Wellness

Indeterminate EIN Presswire

Apr. 27, 2026

WHAT FEELS LIKE ANXIETY OR PANIC ATTACKS COULD BE A RARE ADRENAL TUMOR: PHEOCHROMOCYTOMA WARNING SIGNS

Indeterminate EIN Presswire

Apr. 27, 2026

Dark Watch Launches Integration to Improve Therapist Safety in Service-Based Platforms

Indeterminate EIN Presswire

Apr. 27, 2026

U.S. News & World Report Names Sinai Residences Among Best Senior Living Communities for 2026

Indeterminate EIN Presswire

Apr. 27, 2026

Karns & Karns Personal Injury and Accident Attorneys Expand Florida Operations to Include MVA and Catastrophic Injury

Indeterminate EIN Presswire

Apr. 27, 2026

RCR|HUB Launches Dedicated Revenue Cycle Management Job Board to Meet Surging CommUnity Demand

Indeterminate EIN Presswire

Apr. 27, 2026

Pioneer Health Chief Receives National Certification

Indeterminate EIN Presswire

Apr. 27, 2026

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

Indeterminate GlobeNewswire

Apr. 27, 2026

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

Indeterminate GlobeNewswire

Apr. 27, 2026

KFSH se une a la Conferencia Global 2026 del Instituto Milken en Beverly Hills, California, como patrocinador Silver

Indeterminate GlobeNewswire

Apr. 27, 2026

KFSH Participa da Milken Institute Global Conference 2026 em Beverly Hills, Califórnia, como Patrocinador Prata

Indeterminate GlobeNewswire

Apr. 27, 2026

J3RCM and Loop Announce Strategic Partnership Backed by Champion to Transform Healthcare Delivery

Indeterminate EIN Presswire

Apr. 27, 2026

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

Indeterminate GlobeNewswire

Apr. 27, 2026

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Indeterminate GlobeNewswire

Apr. 27, 2026

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire